Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): protocol for randomized controlled trial.

Vascular Medicine
Roberta K OkaEmile R Mohler

Abstract

Peripheral artery disease (PAD) is an understudied chronic illness most prevalent in elderly individuals. PAD patients experience substantial walking impairment due to symptoms of limb ischemia that significantly diminishes quality of life (QOL). Cardiovascular disease (CVD) morbidity and mortality is increased in this population because of aggressive atherosclerosis resulting from untreated CVD risk factors. Despite current national guidelines recommending intensive CVD risk factor management for PAD patients, untreated CVD risk factors are common. Interventions that bridge this gap are imperative. The Vascular Insufficiency - Goals for Optimal Risk Reduction (VIGOR(2)) study is a randomized controlled trial (RCT) that examines the effectiveness of a long-term multifactor CVD risk reduction program on walking and quality of life in patients with PAD. The purpose of this article is to provide a detailed description of the design and methods of VIGOR(2). Clinical Trial Registration - URL: http://clinicaltrials.gov/ct2/show/NCT00537225.

Associated Clinical Trials

References

Mar 1, 1977·Psychological Review·A Bandura
Jan 1, 1992·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·B H MarcusJ S Rossi
Apr 1, 1991·Medicine and Science in Sports and Exercise·A W GardnerL K Smith
Jan 1, 1985·Addictive Behaviors·J O ProchaskaJ C Norcross
Mar 1, 1974·The American Journal of Nursing·W AveryS Palmer
Aug 1, 1995·The Surgical Clinics of North America·M M McDermott, W McCarthy
Jan 1, 1994·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·J O ProchaskaD Rosenbloom
Aug 6, 1994·American Journal of Health Promotion : AJHP·B H MarcusE R Taylor
Apr 6, 1999·Diabetes Care·A I Adler, R C Turner
Jan 3, 2001·Nursing Outlook·L SaarmannB Riegel
Apr 3, 2001·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Debra Roter
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 19, 2001·Cardiology in Review·M A Creager
Oct 2, 2001·Administration and Policy in Mental Health·J M ProchaskaD A Levesque
May 4, 2002·American Journal of Preventive Medicine·Evelyn P WhitlockJanet Allan
May 25, 2002·Chronobiology International·Eugene L KanabrockiD Craig Hooper
Nov 1, 2002·Health Education Research·Victor StrecherChristine Johnson
Nov 28, 2002·Diabetes Care·UNKNOWN Diabetes Prevention Program (DPP) Research Group
Dec 11, 2002·Journal of General Internal Medicine·Mary McGrae McDermottStacie Hudgens
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Dec 4, 2003·Annals of Internal Medicine·Lisa A CooperNeil R Powe
Apr 20, 2004·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Albert Bandura
Apr 28, 2004·American Journal of Preventive Medicine·Esther M F van SluijsWillem van Mechelen
May 14, 2004·Patient Education and Counseling·Eileen BrittNeville M Blampied
Jun 12, 2004·BMJ : British Medical Journal·Debra Roter
Jun 26, 2004·Journal of Vascular Surgery·Andrew W GardnerLois A Killewich
Jul 28, 2004·American Journal of Preventive Medicine·Nicolaas P PronkMichael G Goldstein
Jul 28, 2004·American Journal of Preventive Medicine·Michael G GoldsteinUNKNOWN Planning Committee of the Addressing Multiple Behavioral Risk Factors in Primary Care Project
Sep 16, 2004·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Albert J BellgUNKNOWN Treatment Fidelity Workgroup of the NIH Behavior Change Consortium
Mar 22, 2005·Nursing Research·Barbara ResnickJay Magaziner
Sep 19, 2007·Circulation·Alan T HirschUNKNOWN Peripheral Arterial Disease Coalition
Dec 23, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Andreas ZellerEdouard Battegay
Jul 9, 2009·Medical Care·Debra L Roter, Judith A Hall
Dec 19, 2009·Circulation·UNKNOWN WRITING GROUP MEMBERSUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 11, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Marie Guidon, Hannah McGee
Jun 18, 2010·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·L NorgrenJ J F Belch
Jul 2, 2010·Mayo Clinic Proceedings·Jeffrey W Olin, Brett A Sealove
Aug 20, 2010·American Journal of Epidemiology·Loki NatarajanJohn P Pierce

❮ Previous
Next ❯

Citations

Nov 8, 2020·Annals of Vascular Surgery·Miquel Coca-MartinezHeather L Gill

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation

Clinical Trials Mentioned

NCT00537225

Software Mentioned

VIGOR

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.